Series B Life Science Companies

Centaur provides a platform and services for expert annotation of medical and scientific data

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Qualifyze provides digital solutions for supply chain risk management in Life Sciences.

GALY produces agriculture from cells in a facility, not plants in the field

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Magnetic Insight is a biotechnology company that offers cellular imaging to measure the efficacy of cancer immunotherapies.

Sware provides validation automation platform and managed services programs.

Prolific Machines unlocks production of next-generation therapeutics with a light-controlled gene expression system and closed-loop control.

Enifer is a mycoprotein company that produces a fungal fermentation product to upcycle agrifood industry byproducts.

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Elegen is a biotechnology company that develops microfluidic technology.

DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.

Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.